Advanced search
Publication Cover
Blood Pressure Volume 14, 2005 - Issue 1
Submit an article Journal homepage
365
Views
56
CrossRef citations to date
0
Altmetric
Original article

The Study on COgnition and Prognosis in the Elderly (SCOPE) – Major CV events and stroke in subgroups of patients

Peter Trenkwalder Department of Internal Medicine, Starnberg Hospital, Ludwig Maximilian University Munich, Starnberg, GermanyCorrespondencepeter.trenkwalder@klinikum‐starnberg.de
,
Dag Elmfeldt AstraZeneca R&D, Clinical Science, Mölndal, Sweden
,
Albert Hofman Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden
,
Hans Lithell Departments of Epidemiology and Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands
,
Bertil Olofsson Department of Cardiology, Veterans Administration Medical Centre, Georgetown University, Washington DC, USA
,
Vasilios Papademetriou Institute of Clinical Neuroscience, Department of Psychiatry, Sahlgrenska University Hospital, Göteborg University, Göteborg, Sweden
,
Ingmar Skoog Centro di Fisiologia Clinica e Ipertensione, University of Milan, Ospedale Maggiore, Instituto Auxologico Italiano, Milano, Italy
&
Alberto Zanchetti Department of Internal Medicine, Starnberg Hospital, Ludwig Maximilian University Munich, Starnberg, Germany
 show all
Pages 31-37 | Received 08 Sep 2004, Accepted 08 Oct 2004, Published online: 08 Jul 2009

Citations (56)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Andreas D Meid, Carmen Ruff, Lucas Wirbka, Felicitas Stoll, Hanna M Seidling, Andreas Groll & Walter E Haefeli. (2020) Using the Causal Inference Framework to Support Individualized Drug Treatment Decisions Based on Observational Healthcare Data. Clinical Epidemiology 12, pages 1223-1234.
Read now
Daniel T. Lackland, Jenifer H. Voeks & Andrea D. Boan. (2016) Hypertension and stroke: an appraisal of the evidence and implications for clinical management. Expert Review of Cardiovascular Therapy 14:5, pages 609-616.
Read now
. (2007) 2007 ESH‐ESC Guidelines for the management of arterial hypertension. Blood Pressure 16:3, pages 135-232.
Read now
Roland Asmar & Sophie Nisse-Durgeat. (2006) A Large Scale Study of Angiotensin II Inhibition Therapy in an Elderly Population: the Chance Study. Vascular Health and Risk Management 2:3, pages 317-323.
Read now
Dimitris P Papadopoulos & Vasilios Papademetriou. (2006) Targeting angiotensin II type I receptors to reduce the risk of stroke in patients with hypertension. Expert Opinion on Therapeutic Targets 10:2, pages 231-237.
Read now
Alberto Zanchetti & Dag Elmfeldt. (2006) Findings and implications of the Study on COgnition and Prognosis in the Elderly (SCOPE) – A review. Blood Pressure 15:2, pages 71-79.
Read now

Articles from other publishers (50)

Qianqian YangRuizhi Zheng, Siyu WangJiamin ZhuMian Li, Tiange Wang, Zhiyun Zhao, Min XuJieli LuYuhong ChenGuang Ning, Weiqing WangYufang BiYu Xu. (2023) Systolic Blood Pressure Control Targets to Prevent Major Cardiovascular Events and Death in Patients With Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. Hypertension 80:8, pages 1640-1653.
Crossref
Chia-Yu Hsu, Jeffrey L. Saver, Bruce Ovbiagele, Yi-Ling Wu, Chun-Yu Cheng & Meng Lee. (2023) Association Between Magnitude of Differential Blood Pressure Reduction and Secondary Stroke Prevention. JAMA Neurology.
Crossref
Xiao-Chun Yang, Li-Li Shao, Ying-Jun Mi, Wen-Hao Zhang, Nuo-Ya Liu, Ruo-Bin Liu, Xiao-Xi Zhou, Wei-Hong Zhang & Qing-Bao Tian. (2021) Effect of renin-angiotensin-aldosterone system inhibitors on all-cause mortality and major cardiovascular events in patients with diabetes: A meta-analysis focusing on the number needed to treat and minimal clinical effect. Journal of Diabetes and its Complications 35:3, pages 107830.
Crossref
Christopher N. Floyd & Anthony S. Wierzbicki. (2020) Reorganizing the treatment of cardiovascular disease in response to coronavirus disease 2019; time for the polypill?. Current Opinion in Cardiology 35:4, pages 428-433.
Crossref
Sanjay Ranjit, Jian Yao Wong, Jia W. Tan, Chee Sin Tay, Jessica M. Lee, Kelly Yin Han Wong, Luminita H. Pojoga, Danielle L. Brooks, Amanda E. Garza, Stephen A. Maris, Isis Akemi Katayama, Jonathan S. Williams, Alicia Rivera, Gail K. Adler, Gordon H. Williams & Jose R. Romero. (2019) Sex-specific differences in endoplasmic reticulum aminopeptidase 1 modulation influence blood pressure and renin-angiotensin system responses. JCI Insight 4:21.
Crossref
Chi-Jung Huang, Chern-En Chiang, Bryan Williams, Kazuomi Kario, Shih-Hsien Sung, Chen-Huan Chen, Tzung-Dau Wang & Hao-Min Cheng. (2019) Effect Modification by Age on the Benefit or Harm of Antihypertensive Treatment for Elderly Hypertensives: A Systematic Review and Meta-analysis. American Journal of Hypertension 32:2, pages 163-174.
Crossref
Costas Thomopoulos, Gianfranco Parati & Alberto Zanchetti. (2018) Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality. Journal of Hypertension 36:8, pages 1622-1636.
Crossref
Costas Thomopoulos, Gianfranco Parati & Alberto Zanchetti. (2018) Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality. Journal of Hypertension 36:8, pages 1637-1647.
Crossref
Bernice Tsoi, Leo E. Akioyamen, Ashley Bonner, Claudia Frankfurter, Mitchell Levine, Eleanor Pullenayegum, Ron Goeree & Daria O’Reilly. (2018) Comparative Efficacy of Angiotensin II Antagonists in Essential Hypertension: Systematic Review and Network Meta-Analysis of Randomised Controlled Trials. Heart, Lung and Circulation 27:6, pages 666-682.
Crossref
Xiaodan lv, Yingshi Zhang, Yixuan Niu, Qi Song & Qingchun Zhao. (2018) Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in hypertensive patients with type 2 diabetes mellitus. Medicine 97:15, pages e0256.
Crossref
Massimo Volpe, Giovanna Gallo & Giuliano Tocci. (2018) Is early and fast blood pressure control important in hypertension management?. International Journal of Cardiology 254, pages 328-332.
Crossref
Costas Thomopoulos, Gianfranco Parati & Alberto Zanchetti. (2017) Effects of blood-pressure-lowering treatment on outcome incidence in hypertension. 11. Effects of total cardiovascular risk and achieved blood pressure. Journal of Hypertension 35:11, pages 2138-2149.
Crossref
Costas Thomopoulos, Gianfranco Parati & Alberto Zanchetti. (2017) Effects of blood-pressure-lowering treatment on outcome incidence in hypertension. Journal of Hypertension 35:5, pages 922-944.
Crossref
Wei-Ting Wang, Li-Kai You, Chern-En Chiang, Shih-Hsien Sung, Shao-Yuan Chuang, Hao-Min Cheng & Chen-Huan Chen. (2016) Comparative Effectiveness of Blood Pressure-lowering Drugs in Patients who have Already Suffered From Stroke. Medicine 95:15, pages e3302.
Crossref
Leo Akioyamen, Mitchell Levine, Diana Sherifali, Daria O'Reilly, Claudia Frankfurter, Eleanor Pullenayegum, Ron Goeree & Bernice Tsoi. (2016) Cardiovascular and cerebrovascular outcomes of long-term angiotensin receptor blockade: meta-analyses of trials in essential hypertension. Journal of the American Society of Hypertension 10:1, pages 55-69.e1.
Crossref
William J. Elliott. 2016. Hypertension and Stroke. Hypertension and Stroke 39 59 .
Jennifer C. SullivanPaula Rodriguez-Miguelez, Margaret A. ZimmermanRyan A. Harris. (2015) Differences in angiotensin (1–7) between men and women. American Journal of Physiology-Heart and Circulatory Physiology 308:9, pages H1171-H1176.
Crossref
Janice B. Schwartz. (2015) Primary prevention: Do the very elderly require a different approach?. Trends in Cardiovascular Medicine 25:3, pages 228-239.
Crossref
Jennifer C. Sullivan. 2015. Sodium and Water Homeostasis. Sodium and Water Homeostasis 91 117 .
Daniel T. Lackland, Edward J. Roccella, Anne F. Deutsch, Myriam Fornage, Mary G. George, George Howard, Brett M. Kissela, Steven J. Kittner, Judith H. Lichtman, Lynda D. Lisabeth, Lee H. Schwamm, Eric E. Smith & Amytis Towfighi. (2014) Factors Influencing the Decline in Stroke Mortality. Stroke 45:1, pages 315-353.
Crossref
Fadi G. Hage, Sulaf J. Mansur, Dongqi Xing & Suzanne Oparil. (2013) Hypertension in women. Kidney International Supplements 3:4, pages 352-356.
Crossref
Yoko M. Nakao, Satoshi Teramukai, Sachiko Tanaka, Shinji Yasuno, Akira Fujimoto, Masato Kasahara, Kenji Ueshima, Kazuhiro Nakao, Shiro Hinotsu, Kazuwa Nakao & Koji Kawakami. (2012) Effects of renin–angiotensin system blockades on cardiovascular outcomes in patients with diabetes mellitus: A systematic review and meta-analysis. Diabetes Research and Clinical Practice 96:1, pages 68-75.
Crossref
Eduardo Pimenta. (2011) Hypertension in women. Hypertension Research 35:2, pages 148-152.
Crossref
Meng LeeJeffrey L. SaverKeun-Sik HongQing HaoJessica ChowBruce Ovbiagele. (2012) Renin–Angiotensin System Modulators Modestly Reduce Vascular Risk in Persons With Prior Stroke. Stroke 43:1, pages 113-119.
Crossref
Hisatomi Arima & John Chalmers. (2011) PROGRESS: Prevention of Recurrent Stroke. The Journal of Clinical Hypertension 13:9, pages 693-702.
Crossref
Dilip K. Pandey & Venkatesh Aiyagari. (2011) Prevention of Second Strokes Through Blood Pressure Lowering: Update for 2011. Current Cardiovascular Risk Reports 5:4, pages 299-306.
Crossref
M R Weir, D Zappe, L A Orloski & J R Sowers. (2010) How early should blood pressure control be achieved for optimal cardiovascular outcomes?. Journal of Human Hypertension 25:4, pages 211-217.
Crossref
William J. Elliott. 2011. Hypertension and Stroke. Hypertension and Stroke 41 59 .
Gerald Gartlehner, Andrea Chapman, Michaela Strobelberger & Kylie Thaler. (2010) Differences in Efficacy and Safety of Pharmaceutical Treatments between Men and Women: An Umbrella Review. PLoS ONE 5:7, pages e11895.
Crossref
Hiroshi Yoshida, Mitsuyuki Shimizu, Katsunori Ikewaki, Ikuo Taniguchi, Norio Tada, Michihiro Yoshimura, Giuseppe Rosano, Björn Dahlöf & Seibu Mochizuki. (2010) Sex differences in effects of valsartan administration on cardiovascular outcomes in hypertensive patients: findings from the Jikei Heart Study: Retracted. Journal of Hypertension 28:6, pages 1150-1157.
Crossref
W.J. Elliott. (2010) Association of higher diastolic blood pressure levels with cognitive impairment. Yearbook of Cardiology 2010, pages 29-30.
Crossref
Dimitris P. PapadopoulosVasilios PapademetriouThomas K. Makris. (2009) On Target to Dual Block RAS?. Angiology 60:6, pages 739-749.
Crossref
Lisheng Liu, Zengwu Wang, Lansheng Gong, Yuqing Zhang, Lutgarde Thijs, Jan A Staessen & Jiguang Wang. (2009) Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature. Hypertension Research 32:11, pages 1032-1040.
Crossref
Alan H. Gradman. (2009) Role of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Hypertension in Patients Aged ≥65 Years. Drugs & Aging 26:9, pages 751-767.
Crossref
A. Kautzky-Willer & A. Handisurya. (2009) Metabolic diseases and associated complications: sex and gender matter!. European Journal of Clinical Investigation 39:8, pages 631-648.
Crossref
Charlotta LjungmanLena MortensenThomas KahanKarin Manhem. (2009) Treatment of Mild to Moderate Hypertension by Gender Perspective: A Systematic Review. Journal of Women's Health 18:7, pages 1049-1062.
Crossref
V V Fomin. (2009) Perspectives of using angiotensin receptor antagonists. Systemic Hypertension 6:2, pages 38-43.
Crossref
Vasilios Papademetriou. (2009) Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic events. American Heart Journal 157:6, pages S24-S30.
Crossref
Susana Pérez Zamora, Mencia Benítez Camps, Antoni Dalfó Baqué, Mar Piqueras Garré, Gustavo Losada Duval & María Antonia Vila Coll. (2008) ¿Es adecuada la actitud que adoptan los médicos de atención primaria en Cataluña ante la insuficiente reducción de cifras de presión arterial en los pacientes hipertensos? Estudio DISEHTAC-2001. Atención Primaria 40:10, pages 505-510.
Crossref
Alejandro de la Sierra, Manuel Gorostidi, Rafael Marín, Josep Redón, José R. Banegas, Pedro Armario, Juan García Puig, Julio Zarco, José L. Llisterri, Carlos Sanchís, Benjamín Abarca, Vicente Palomo, Ramón Gomis, Alfonso Otero, Fernando Villar, Jesús Honorato, Juan Tamargo, José M. Lobos, Juan Macías-Núñez, Antonio Sarría, Pedro Aranda & Luis M. Ruilope. (2008) Evaluación y tratamiento de la hipertensión arterial en España. Documento de consenso. Medicina Clínica 131:3, pages 104-116.
Crossref
D.M. Rabi, N. Khan, M. Vallee, M.A. Hladunewich, S.W. Tobe & L. Pilote. (2008) Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy. Canadian Journal of Cardiology 24:6, pages 491-496.
Crossref
Ingrid OsVeronica FrancoSverre E. KjeldsenKarin ManhemRichard B. DevereuxEva GerdtsDarcy A. HillePaulette A. LylePeter M. OkinBjörn DahlöfSuzanne Oparil. (2008) Effects of Losartan in Women With Hypertension and Left Ventricular Hypertrophy. Hypertension 51:4, pages 1103-1108.
Crossref
Giuseppe Mancia & Guido Grassi. (2008) Editorial. Therapeutic Advances in Cardiovascular Disease 2:1, pages 5-12.
Crossref
Lillian C. Min, Rajnish Mehrotra & Constance H. Fung. (2007) Quality Indicators for the Care of Hypertension in Vulnerable Elders. Journal of the American Geriatrics Society 55, pages S359-S365.
Crossref
. (2007) Guías de práctica clínica para el tratamiento de la hipertensión arterial 2007. Revista Española de Cardiología 60:9, pages 968.e1-968.e94.
Crossref
I P Kolos, T V Martynyuk & I E Chazova. (2007) Fiksirovannaya kombinatsiya perindoprila i indapamida u patsientov s arterial'noy gipertenziey v usloviyakh real'noy klinicheskoy praktiki. Systemic Hypertension 4:2, pages 21-26.
Crossref
Alberto Zanchetti, Stevo Julius, Sverre Kjeldsen, Gordon T McInnes, Tsushung Hua, Michael Weber, John H Laragh, Francis Plat, Edouard Battegay, Cesar Calvo-Vargas, Andrzej Cieśliński, Jean Paul Degaute, Nicolaas J Holwerda, Janna Kobalava, Ole Lederballe Pedersen, Faustinus P Rudyatmoko, Kostas C Siamopoulos & Öyvind Störset. (2006) Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial. Journal of Hypertension 24:11, pages 2163-2168.
Crossref
Peter Trenkwalder. (2006) The Study on COgnition and Prognosis in the Elderly (SCOPE) – recent analyses. Journal of Hypertension 24:Suppl 1, pages S107-S114.
Crossref
J N Basile & S Chrysant. (2006) The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapy. Journal of Human Hypertension 20:3, pages 169-175.
Crossref
L. B. Goldstein & G. J. Hankey. (2006) Advances in Primary Stroke Prevention. Stroke 37:2, pages 317-319.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.